1. Home
  2. RFL vs SACH Comparison

RFL vs SACH Comparison

Compare RFL & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • SACH
  • Stock Information
  • Founded
  • RFL 2017
  • SACH 2010
  • Country
  • RFL United States
  • SACH United States
  • Employees
  • RFL N/A
  • SACH N/A
  • Industry
  • RFL Real Estate
  • SACH Real Estate Investment Trusts
  • Sector
  • RFL Finance
  • SACH Real Estate
  • Exchange
  • RFL Nasdaq
  • SACH Nasdaq
  • Market Cap
  • RFL 54.4M
  • SACH 54.4M
  • IPO Year
  • RFL N/A
  • SACH 2017
  • Fundamental
  • Price
  • RFL $1.34
  • SACH $1.30
  • Analyst Decision
  • RFL
  • SACH Hold
  • Analyst Count
  • RFL 0
  • SACH 4
  • Target Price
  • RFL N/A
  • SACH $2.25
  • AVG Volume (30 Days)
  • RFL 110.9K
  • SACH 239.7K
  • Earning Date
  • RFL 11-05-2025
  • SACH 08-05-2025
  • Dividend Yield
  • RFL N/A
  • SACH 15.44%
  • EPS Growth
  • RFL N/A
  • SACH N/A
  • EPS
  • RFL N/A
  • SACH N/A
  • Revenue
  • RFL $732,000.00
  • SACH N/A
  • Revenue This Year
  • RFL N/A
  • SACH N/A
  • Revenue Next Year
  • RFL N/A
  • SACH $7.74
  • P/E Ratio
  • RFL N/A
  • SACH N/A
  • Revenue Growth
  • RFL 35.56
  • SACH N/A
  • 52 Week Low
  • RFL $1.28
  • SACH $0.80
  • 52 Week High
  • RFL $3.19
  • SACH $2.70
  • Technical
  • Relative Strength Index (RSI)
  • RFL 38.86
  • SACH 61.34
  • Support Level
  • RFL $1.30
  • SACH $1.26
  • Resistance Level
  • RFL $1.51
  • SACH $1.27
  • Average True Range (ATR)
  • RFL 0.11
  • SACH 0.06
  • MACD
  • RFL -0.00
  • SACH 0.01
  • Stochastic Oscillator
  • RFL 12.90
  • SACH 73.68

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

Share on Social Networks: